Real-time PCR expression profiling of genes encoding potential virulence factors in Candida albicans biofilms: identification of model-dependent and -independent gene expression.
BACKGROUND
Candida albicans infections are often associated with biofilm formation. Previous work demonstrated that the expression of HWP1 (hyphal wall protein) and of genes belonging to the ALS (agglutinin-like sequence), SAP (secreted aspartyl protease), PLB (phospholipase B) and LIP (lipase) gene families is associated with biofilm growth on mucosal surfaces. We investigated using real-time PCR whether genes encoding potential virulence factors are also highly expressed in biofilms associated with abiotic surfaces. For this, C. albicans biofilms were grown on silicone in microtiter plates (MTP) or in the Centres for Disease Control (CDC) reactor, on polyurethane in an in vivo subcutaneous catheter rat (SCR) model, and on mucosal surfaces in the reconstituted human epithelium (RHE) model.


RESULTS
HWP1 and genes belonging to the ALS, SAP, PLB and LIP gene families were constitutively expressed in C. albicans biofilms. ALS1-5 were upregulated in all model systems, while ALS9 was mostly downregulated. ALS6 and HWP1 were overexpressed in all models except in the RHE and MTP, respectively. The expression levels of SAP1 were more pronounced in both in vitro models, while those of SAP2, SAP4 and SAP6 were higher in the in vivo model. Furthermore, SAP5 was highly upregulated in the in vivo and RHE models. For SAP9 and SAP10 similar gene expression levels were observed in all model systems. PLB genes were not considerably upregulated in biofilms, while LIP1-3, LIP5-7 and LIP9-10 were highly overexpressed in both in vitro models. Furthermore, an elevated lipase activity was detected in supernatans of biofilms grown in the MTP and RHE model.


CONCLUSIONS
Our findings show that HWP1 and most of the genes belonging to the ALS, SAP and LIP gene families are upregulated in C. albicans biofilms. Comparison of the fold expression between the various model systems revealed similar expression levels for some genes, while for others model-dependent expression levels were observed. This suggests that data obtained in one biofilm model cannot be extrapolated to other model systems. Therefore, the need to use multiple model systems when studying the expression of genes encoding potential virulence factors in C. albicans biofilms is highlighted.
Nailis
Heleen
H
Laboratory for Pharmaceutical Microbiology, Universiteit Gent, Harelbekestraat 72, B-9000, Ghent, Belgium.
Kucharíková
Sona
S
Ricicová
Markéta
M
Van Dijck
Patrick
P
Deforce
Dieter
D
Nelis
Hans
H
Coenye
Tom
T
D000818:Animals; D018441:Biofilms / Q000254:growth & development*; D002176:Candida albicans / Q000235:genetics / Q000254:growth & development / Q000502:physiology*; D002404:Catheterization; D004847:Epithelial Cells / Q000382:microbiology; D004864:Equipment and Supplies / Q000382:microbiology; D005656:Fungal Proteins / Q000096:biosynthesis*; D020869:Gene Expression Profiling; D015966:Gene Expression Regulation, Fungal; D006801:Humans; D051381:Rats; D017207:Rats, Sprague-Dawley; D020133:Reverse Transcriptase Polymerase Chain Reaction / Q000379:methods; D037521:Virulence Factors / Q000096:biosynthesis*
D005656:Fungal Proteins; D037521:Virulence Factors
Science. 1999 Mar 5;283(5407):1535-8
10066176
PLoS Pathog. 2006 Jul;2(7):e63
16839200
Microbiology (Reading). 2005 May;151(Pt 5):1619-1630
15870470
Curr Opin Microbiol. 2002 Dec;5(6):608-11
12457706
FEMS Microbiol Lett. 1998 Feb 1;159(1):129-35
9485603
Mol Cell Probes. 2005 Jun;19(3):153-62
15797814
Nat Protoc. 2006;1(6):2767-73
17406503
Microbiology (Reading). 2008 Nov;154(Pt 11):3281-3295
18957582
Microbiology (Reading). 2008 Nov;154(Pt 11):3266-3280
18957581
Curr Opin Microbiol. 2006 Dec;9(6):588-94
17055772
Trends Microbiol. 2001 Apr;9(4):176-80
11286882
BMC Mol Biol. 2006 Aug 04;7:25
16889665
Trends Microbiol. 2003 Jan;11(1):30-6
12526852
Eukaryot Cell. 2006 Oct;5(10):1604-10
17030992
Microbiology (Reading). 2005 Apr;151(Pt 4):1051-1060
15817774
Eukaryot Cell. 2004 Apr;3(2):536-45
15075282
Med Mycol. 2008 Feb;46(1):1-15
17852717
Microbiology (Reading). 2006 Aug;152(Pt 8):2287-2299
16849795
Curr Opin Microbiol. 2004 Aug;7(4):336-41
15288621
Microbiol Mol Biol Rev. 2003 Sep;67(3):400-28, table of contents
12966142
J Biol Chem. 2006 Jan 13;281(2):688-94
16269404
Trends Microbiol. 2001 Jul;9(7):327-35
11435107
Microbiology (Reading). 2007 Aug;153(Pt 8):2373-2385
17660402
Annu Rev Microbiol. 2005;59:113-33
16153165
Microbiology (Reading). 2004 Feb;150(Pt 2):267-275
14766904
Mycopathologia. 2009 Jan;167(1):9-17
18683080
Infect Immun. 1994 Mar;62(3):915-21
8112864
Nucleic Acids Res. 2010 Jan;38(Database issue):D428-32
19808938
J Infect Dis. 2009 Jul 15;200(2):307-13
19527170
Mycoses. 2005 Nov;48(6):365-77
16262871
Arch Microbiol. 2000 Nov;174(5):362-74
11131027
APMIS. 2006 Dec;114(12):857-66
17207086
J Microbiol Methods. 2009 Aug;78(2):171-4
19464327
Curr Genet. 1998 Jun;33(6):451-9
9644209
Clin Microbiol Rev. 2004 Apr;17(2):255-67
15084500
Cell Microbiol. 2002 Aug;4(8):461-9
12174081
Curr Biol. 2008 Jul 22;18(14):1017-24
18635358
Cell Microbiol. 2007 Dec;9(12):2938-54
17645752
Microbiology (Reading). 2010 Mar;156(Pt 3):909-919
19959578
FEMS Yeast Res. 2004 Jan;4(4-5):401-8
14734020
Infect Immun. 2004 Oct;72(10):6023-31
15385506
Nucleic Acids Res. 1997 Sep 1;25(17):3389-402
9254694
Eukaryot Cell. 2005 Sep;4(9):1562-73
16151249
Antimicrob Agents Chemother. 2004 May;48(5):1727-32
15105127
Med Mycol. 2007 Aug;45(5):429-34
17654269
Clin Microbiol Rev. 2000 Jan;13(1):122-43, table of contents
10627494
Biol Pharm Bull. 2007 Sep;30(9):1813-5
17827747
Nat Rev Microbiol. 2008 Sep;6(9):667-73
18679170